Ethyl 3-cyclobutyl-3-oxopropanoate

Catalog No.: 
ACNAFC804
CAS No.: 
24922-01-8
Molecular Formula: 
C9H14O3
Molecular Weight: 
170.21
Ethyl 3-cyclobutyl-3-oxopropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$63.00In stockIn stock
25g98%$230.00In stockIn stock
100g98%$804.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-cyclobutyl-3-oxopropanoate
IUPAC Nameethyl 3-cyclobutyl-3-oxopropanoate
MDL No.MFCD06410651
Molecular FormulaC9H14O3
Molecular Weight170.21
SMILESO=C(OCC)CC(C1CCC1)=O
InChI KeyHYHZQZSNOAJEPU-UHFFFAOYSA-N
Synonymethyl 3-cyclobutyl-3-oxopropanoate | 24922-01-8 | 3-CYCLOBUTYL-3-OXO-PROPIONIC ACID ETHYL ESTER | MFCD06410651 | Cyclobutanepropanoic acid, beta-oxo-, ethyl ester | ethyl3-cyclobutyl-3-oxopropanoate | Cyclobutanepropanoicacid, b-oxo-, ethyl ester | AMY351 | SCHEMBL200527
CAS No.24922-01-8
PubChem CID21846412

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACNAFC804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNUTW093 route compound structure diagram
    ACNUTW0935006-22-4In Stock
  4. Then
  5. ACNAFC804 route product structure diagram
    ACNAFC80424922-01-8In Stock
Inquiry

2. ACNAFC804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNAFC804 route product structure diagram
    ACNAFC80424922-01-8In Stock
Inquiry

3. ACNAFC804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNAFC804 route product structure diagram
    ACNAFC80424922-01-8In Stock
Inquiry

Comments (0)